SAN FRANCISCO, Nov. 15, 2016 /PRNewswire/ -- Benchling, the next-generation life science R&D software company, today announced the launch of its Bioregistry system, releasing groundbreaking ...
SAN FRANCISCO, Aug. 20, 2026 /PRNewswire/ -- Benchling today announced its expansion into chemistry, bringing chemistry and biology together on one connected platform for scientific research and ...
Benchling AI debuts alongside major new capabilities for antibody discovery, automated data analysis, and development BOSTON, Oct. 14, 2025 /PRNewswire/ -- Benchling today unveiled major new ...
Last year, Benchling raised $200 million through a series E round to help expand its digital platform followed by a $100 million series F just over six months later ...
– Benchling, the leading life sciences cloud, today announced the launch of RNA Therapeutics R&D, a new digital solution that allows scientists to design, analyze, and develop complex RNA therapeutics ...
Investors are eager for the Benchling IPO. The company made headlines when it confidentially filed with the SEC to go public. Biotechnology is rewriting life as we know it. Our customers, spanning ...
Benchling’s unicorn status didn’t come overnight. Some 10 years after its founding, the company is worth more than $6 billion, and the founder sees the company going public in the future. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results